Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Unexplained macrocytosis in elderly patients

M Y Mahmoud1, M Lugon, C C Anderson

  • 1Department of Haematology, Whipps Cross Hospital, Leytonstone, London.

Age and Ageing
|July 1, 1996
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Immune Class Regulation and Its Medical Significance Part II of a Report of a Workshop on Foundational Concepts of Immune Regulation.

Scandinavian journal of immunology·2017
Same author

Immunological Tolerance. Part I of a Report of a Workshop on Foundational Concepts of Immune Regulation.

Scandinavian journal of immunology·2016
Same author

Recombinant Alpha 2A Interferon-An Effective Maintenance Agent in Essential Thrombocythaemia.

Leukemia & lymphoma·2016
Same author

Prioritizing investments in public health: a multi-criteria decision analysis.

Journal of public health (Oxford, England)·2012
Same author

Targeting cells causing split tolerance allows fully allogeneic islet survival with minimal conditioning in NOD mixed chimeras.

American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons·2012
Same author

Programmed death-1 is required for systemic self-tolerance in newly generated T cells during the establishment of immune homeostasis.

Journal of autoimmunity·2011
Same journal

How social, psychological, and spiritual needs are supported in the last months of life: evidence from the English Longitudinal Study of Ageing end-of-life interviews.

Age and ageing·2026
Same journal

Are there sex differences in the influence of insomnia symptoms and sleep duration on the trajectory of neuromuscular strength decline?

Age and ageing·2026
Same journal

Factors associated with mortality in older sepsis patients: a nationwide retrospective cohort study in Germany.

Age and ageing·2026
Same journal

Frailty phenotype transitions and functional improvements during a supervised exercise trial in older people with HIV: results from the HEALTH Trial.

Age and ageing·2026
Same journal

Overlapping premorbid frailty, multimorbidity and malnutrition and their associations with poor outcomes in patients with stroke.

Age and ageing·2026
Same journal

Overall and cause-specific mortality and associated risk factors among middle-aged and older South Africans: findings from the health and ageing in Africa: a longitudinal study of an INDEPTH community in rural South Africa (HAALSI).

Age and ageing·2026
See all related articles

Diagnosing the cause of macrocytosis in elderly patients is challenging. Many older adults with macrocytosis may have undiagnosed myelodysplastic syndromes (MDS) or evolving MDS.

Area of Science:

  • Geriatric Medicine
  • Hematology
  • Clinical Diagnostics

Background:

  • Macrocytosis, defined as a mean corpuscular volume (MCV) greater than 95 fL, is a common finding in elderly populations.
  • Determining the underlying etiology of macrocytosis in patients over 75 years old can be complex, often requiring invasive procedures.
  • Myelodysplastic syndromes (MDS) are a group of clonal hematopoietic stem cell disorders characterized by ineffective hematopoiesis and increased risk of transformation to acute myeloid leukemia, often presenting with macrocytosis.

Purpose of the Study:

  • To investigate the diagnostic yield of non-invasive techniques versus bone marrow biopsy in identifying the cause of macrocytosis in patients aged 75 years and older.
  • To assess the prevalence of myelodysplastic syndromes (MDS) and potential early-stage MDS in this elderly cohort presenting with macrocytosis.

Related Experiment Videos

Main Methods:

  • A cohort of 124 patients aged 75 years or older with macrocytosis (MCV > 95 fL) was evaluated.
  • Initial assessment utilized non-invasive diagnostic techniques.
  • Patients without a definitive diagnosis underwent bone marrow biopsy for further investigation.

Main Results:

  • A definitive diagnosis for macrocytosis was achieved in 75 out of 124 patients (60%) using non-invasive methods.
  • Bone marrow biopsy identified myelodysplastic syndromes (MDS) in an additional six patients.
  • A significant proportion of the remaining patients exhibited morphological abnormalities suggestive of, but not fitting, recognized pathological entities, potentially indicating MDS in evolution.

Conclusions:

  • Non-invasive methods are effective in diagnosing the cause of macrocytosis in a majority of elderly patients.
  • Bone marrow biopsy remains crucial for diagnosing identifiable myelodysplastic syndromes (MDS) in a subset of patients.
  • Many elderly patients with unexplained macrocytosis may have morphological features indicative of evolving myelodysplastic syndromes (MDS).